Cinqair Side Effects

Generic name: reslizumab

Medically reviewed by Drugs.com. Last updated on Oct 2, 2024.

Note: This document provides detailed information about Cinqair Side Effects associated with reslizumab. Some dosage forms listed on this page may not apply specifically to the brand name Cinqair.

Applies to reslizumab: intravenous solution.

Important warnings This medicine can cause some serious health issues

Intravenous route (solution)

Anaphylaxis has been observed with reslizumab infusion in 0.3% of patients in placebo-controlled clinical studies.

Anaphylaxis was reported as early as the second dose of reslizumab.

Anaphylaxis can be life-threatening.

Patients should be observed for an appropriate period of time after reslizumab administration by a healthcare professional prepared to manage anaphylaxis.

Discontinue reslizumab immediately if the patient experiences signs or symptoms of anaphylaxis.

Common side effects of Cinqair

Some side effects of reslizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common side effects

• throat pain

Incidence not known

• bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

Serious side effects of Cinqair

Along with its needed effects, reslizumab (the active ingredient contained in Cinqair) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking reslizumab:

Rare side effects

• cough
• difficulty with swallowing
• dizziness
• dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
• fast heartbeat
• hives, itching, or skin rash
• puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
• redness of the skin
• tightness in the chest
• unusual tiredness or weakness

For healthcare professionals

Applies to reslizumab: intravenous solution.

Gastrointestinal adverse events

• Common (1% to 10%): Oropharyngeal pain^[Ref]

Hematologic

• Very common (10% or more): Elevated baseline creatine phosphokinase (CPK) (14%)^[Ref]

Hypersensitivity

• Uncommon (0.1% to 1%): Anaphylaxis^[Ref]

Immunologic

• Common (1% to 10%): Treatment emergent anti-reslizumab (the active ingredient contained in Cinqair) antibody response (low titer and often transient)^[Ref]

Musculoskeletal

• Very common (10% or more): Elevated baseline creatine phosphokinase (CPK) (14%)
• Common (1% to 10%): Myalgia, chest pain, neck pain, muscle spasms, extremity pain, muscle fatigue, musculoskeletal pain^[Ref]

Oncologic

• Frequency not reported: Malignancy^[Ref]

Frequently asked questions

• Does Cinqair treat all types of asthma?

Further information

Cinqair side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer